HLA class II antigen expression in human papillomavirus-associated cervical cancer.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

HLA class II antigen expression in human papillomavirus-associated cervical cancer.

Cancer research - 15 Jul 1992

Glew S S, Duggan-Keen M, Cabrera T, Stern P L

Abstract excerpt

The observation that tumor cells of some neoplasms display major histocompatibility complex (MHC) class II molecules may be of functional significance, influencing the progression of malignancy by allowing the cancer cells to present antigen to the immune system. In the normal cervix, class II mo...

Topics

Adult
Aged
Antigens, Surface
CD58 Antigens
Carcinoma, Squamous Cell
Cell Adhesion Molecules
Cervix Uteri
DNA, Viral
Female
HLA-DP Antigens
HLA-DQ Antigens
HLA-DR Antigens
Histocompatibility Antigens Class I
Histocompatibility Antigens Class II
Humans
Intercellular Adhesion Molecule-1
Leukocyte Count
Lymphocytes, Tumor-Infiltrating

Source

Open in PubMed

Identifiers

PMID: 1377602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1377602-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics